Devices and methods for protecting against neuromas
The subject invention provides devices and methods for alleviating discomfort associated with neuroma formation. The devices and methods of the invention effectively use the body's natural response of reconstructing implanted biomaterials to minimize the size of, isolate, and protect a neuroma. In preferred embodiments, the subject device is a cylindrical cap, wherein the internal chamber of the cylindrical cap physically partitions the nerve to enable an arrangement of nerve fibers (as opposed to haphazardly arranged nerve fibers often produced in neuromas). Tabs arranged on the outside of the cap can be used to manipulate the cap into place on a nerve. The open end can also be configured with flaps that can be used to widen the open end for easier insertion of the nerve into the cap. In addition, the cap's material remodels into a tissue cushion after implantation, which protects the neuroma from being stimulated and inducing pain.
1. A cap for alleviating discomfort associated with neuroma formation, the cap comprising:
a body having a distal end and a proximal end, wherein the body comprises:
a single opening located at the proximal end of the body;
an internal chamber defined by the body and extending from the proximal end towards the distal end; and
at least one divider within the internal chamber that subdivides at least a portion of the internal chamber at a distal end of the internal chamber;
wherein the internal chamber includes a retaining cavity between the single opening at the proximal end and the at least one divider.
2. The cap of claim 1 , wherein the body comprises a biomaterial that is configured to remodel around a terminal nerve end to form a tissue cushion.
3. The cap of claim 1 , wherein the at least one divider divides the internal chamber into two or more separate channels, and wherein the at least one divider comprises a biomaterial configured to remodel around the two or more separate channels to form a tissue cushion between the subdivided portions of the internal chamber.
4. The cap of claim 1 , wherein the cap comprises a biomaterial selected from the group consisting of: high-density polyethylene (HDPE), polyethylene glycol (PEG) hydrogel, purified protein from human or animal sources, and decellularized tissue constructs.
5. The cap of claim 4 , wherein the biomaterial is selected from one or more of the group consisting of: collagen, fibrin, demineralized bone, amnion, small intestine submucosa (SIS), dermis, and fascia.
6. The cap of claim 1 , wherein the body is formed of multiple layers of biomaterial.
7. The cap of claim 1 , wherein the body is formed of SIS.
8. The cap of claim 1 , further comprising at least one tab extending from the body.
9. The cap of claim 8 , wherein the at least one tab extends from one or more of a side of the body, the distal end of the body, or an edge of the single opening in the body.
10. A method for covering and containing a neuroma mass at a terminal nerve end using the cap of claim 9 , the method comprising:
using the at least one tab to manipulate the cap onto the terminal nerve end;
inserting the terminal nerve end through the single opening of the cap and into the retaining cavity; and
securing the cap to the terminal nerve end to contain the neuroma mass as it develops.
11. The method of claim 10 , wherein securing the cap to the terminal nerve end comprises attaching the at least one tab to other structures to secure the position of the cap and the terminal nerve end therein.
12. A method for preventing neuroma formation at a terminal nerve end using the cap of claim 9 , the method comprising:
using the at least one tab to manipulate the cap onto the terminal nerve end;
inserting the terminal nerve end through the single opening of the cap and into the retaining cavity; and
securing the cap to the terminal nerve end.
13. The method of claim 12 , wherein securing the cap to the terminal nerve end comprises attaching the at least one tab to other structures to secure the position of the cap and terminal nerve end therein.
14. A method for protecting from stimuli a neuroma mass at a terminal nerve end using the cap of claim 9 , the method comprising:
using the at least one tab to manipulate the cap onto the terminal nerve end;
inserting the terminal nerve end through the single opening of the cap and into the retaining cavity; and
securing the cap to the terminal nerve end to protect the neuroma mass as it develops.
15. The method of claim 14 , wherein securing the cap to the terminal nerve end comprises attaching the at least one tab to other structures to secure the position of the cap and the terminal nerve end therein.
16. The cap of claim 1 , further comprising at least one flap configured around at least a portion of the single opening of the body, wherein the at least one flap forms a slot to increase the size of the single opening, and wherein the at least one flap is adapted to be wrapped around a terminal nerve end to close the slot and reduce the size of the single opening around the terminal nerve end.
17. A method for covering and containing a neuroma mass at a terminal nerve end using the cap of claim 16 , the method comprising:
spreading the at least one flap;
inserting the terminal nerve end through the single opening of the cap and into the retaining cavity; and
securing the cap to the terminal nerve end to contain the neuroma mass as it develops.
18. A method for preventing neuroma formation at a terminal nerve end using the cap of claim 16 , the method comprising:
spreading the at least one flap;
inserting the terminal nerve end through the single opening of the cap and into the retaining cavity; and
securing the cap to the terminal nerve end.
19. A method for protecting from stimuli a neuroma mass at a terminal nerve end using the cap of claim 16 , the method comprising:
spreading the at least one flap;
inserting the terminal nerve end through the single opening of the cap and into the retaining cavity; and
securing the cap to the terminal nerve end to protect the neuroma mass as it develops.
20. The cap of claim 1 , wherein the at least one divider comprises a plurality of dividers, and wherein the plurality of dividers are unconnected from one another.
21. The cap of claim 1 , wherein the at least one divider comprises a plurality of dividers, and wherein the at least a portion of the plurality of dividers directly connect with one another.
22. The cap of claim 1 , wherein the at least one divider comprises at least one of a panel, a spiral-shaped wall, or concentric tubes.
23. The cap of claim 1 , wherein the at least one divider comprises a plurality of panels arranged perpendicularly or parallel to each other within the internal chamber.
24. A method for covering and containing a neuroma mass at a terminal nerve end using the cap of claim 1 , the method comprising:
inserting the terminal nerve end through the single opening of the cap and into the retaining cavity; and
securing the cap to the terminal nerve end to contain the neuroma mass as it develops.
25. A method for preventing neuroma formation at a terminal nerve end using the cap of claim 1 , the method comprising:
inserting the terminal nerve end through the single opening of the cap and into the retaining cavity; and
securing the cap to the terminal nerve end to prevent neuroma formation.
26. A method for protecting from stimuli a neuroma mass at a terminal nerve end using the cap of claim 1 , the method comprising:
inserting the terminal nerve end through the single opening of the cap and into the retaining cavity; and
securing the cap to the terminal nerve end to protect the neuroma mass as it develops.